Find clinical trials for Prostate Cancer in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near New Haven, CT, USA:
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
Commack, New York, United States and 92 other locations
pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...
Phase 1
New Haven, Connecticut, United States and 25 other locations
Assessment of the safety and efficacy of HLD-0915 as monotherapy in patients with metastatic castration resistant prostate cancer (...
Phase 1, Phase 2
New Haven, Connecticut, United States and 10 other locations
This study is being conducted to learn more about the safety, tolerability, and effectiveness of an experimental treatment for metastatic prostate...
Phase 1, Phase 2
Commack, New York, United States and 12 other locations
Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...
Phase 3
Hawthorne, New York, United States and 42 other locations
A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...
Phase 1, Phase 2
New Haven, Connecticut, United States and 22 other locations
is a safe and effective way to treat previously untreated metastatic prostate cancer, and to see whether the study treatment works ...
Phase 2
Commack, New York, United States and 7 other locations
The goal of this clinical trial is to measure the toxicity and effectiveness of the following treatments for cFIR/cgUIR prostate cancer...
Phase 2
New Haven, Connecticut, United States and 1 other location
The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...
Phase 1
New Haven, Connecticut, United States and 54 other locations
with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....
Phase 4
Hartford, Connecticut, United States and 53 other locations
Clinical trials
Research sites
Resources
Legal